Lazard Ltd
NYSE:LAZFinancial - Capital Markets
+$0.45 today
- Market cap
- $3.85B
- Beta
- 1.41
- P/E (TTM)
- 15.7
- EPS (TTM)
- $2.79
- Dividend yield
- 4.58%
Volume 1.38M
Average 1.53M
LAZ Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Lazard LtdNYSE: LAZ
Capital Expenditures · Q3 FY2026 · quarter ended Sep 2026
Capital expenditures turns negative
Q3 FY2026 capital expenditures was -$5.63M, compared with $25.51M a year earlier. Trailing-twelve-month capital expenditures was -$9.21M. Over 3 fiscal years it compounded at -13.6% a year.
Context
- Capital expenditures amounted to 1.0% of revenue in FY2025, down 0.5 pp from a year earlier.
- Capital expenditures grew in size in 1 of the last 3 fiscal years.
What to watch
Whether quarterly capital expenditures holds near -$5.63M or moves back toward the trailing-twelve-month quarterly average of -$2.3M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (31.95M) USD
- Year-over-year change
- +29.8%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (31.95M) | +29.8% |
| FY2024 | 2024-12-31 | (45.5M) | -60.8% |
| FY2023 | 2023-12-31 | (28.3M) | +42.8% |
| FY2022 | 2022-12-31 | (49.51M) | -24.7% |
| FY2021 | 2021-12-31 | (39.7M) | — |
Capital Expenditures vs competitors
How LAZ compares with its peers on the latest reported figures
- LAZ's LTM Sep 2026 capital expenditures of $9.21M is the smallest of the 11 companies compared; the peer median is $53.06M.
- Its year-over-year change of -38.1% is the 9th highest of 11, against a peer median of +10.2%.
- Capital expenditures amounts to 0.3% of revenue for LAZ, versus a peer median of 1.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $197M | +1.5% | +27.4% | 1.2% | |
| LTM Jun 2026 | $73.2M | +18.8% | +9.7% | 0.0% | |
| LTM Jun 2026 | $63.91M | -5.7% | +4.0% | 1.9% | |
| LTM Jun 2026 | $60.04M | +0.7% | +32.7% | 1.5% | |
| LTM Jun 2026 | $54.93M | +348.6% | +82.7% | 3.5% | |
| LTM Jun 2026 | $51.19M | +223.1% | +137.3% | 2.7% | |
| LTM Jun 2026 | $37.04M | -731.5% | -23.9% | 2.0% | |
| LTM Jun 2026 | $25.34M | +429.6% | +63.2% | 1.1% | |
| LTM Jun 2026 | $19.24M | -46.9% | +4.2% | 0.9% | |
| LTM Sep 2026 | $18.64M | +52.2% | -5.2% | 2.1% | |
| LTM Sep 2026 | $9.21M | -38.1% | -13.6% | 0.3% | |
| Peer median (excluding LAZ) | $53.06M | +10.2% | +18.5% | 1.7% | |
Competitors are the stored peer set for LAZ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 542.55M | 392.48M | (75.48M) | 273.03M | 230.91M |
| Depreciation & Amortization | 112.4M | 103.02M | 42.85M | 36.28M | 34.19M |
| Deferred Income Tax | 92.84M | 41.5M | 0 | 2.83M | 0 |
| Stock-Based Compensation | 394.11M | 406.24M | 250.57M | 448.49M | 0 |
| Change in Working Capital | (299.47M) | (109.29M) | (240.87M) | 16.27M | (275.02M) |
| Accounts Receivables | (81.61M) | 140.75M | (100.5M) | (3.58M) | (62.25M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | (217.86M) | (250.04M) | (140.37M) | 19.84M | (212.77M) |
| Other Non-Cash Items | 23.65M | 32K | 187.59M | (34.06M) | 547.1M |
| Operating Cash Flow | 866.08M | 833.98M | 164.66M | 742.83M | 537.18M |
| Capital Expenditures | (39.7M) | (49.51M) | (28.3M) | (45.5M) | (31.95M) |
| Acquisitions (Net) | 642K | 573K | (10.52M) | (17.49M) | 0 |
| Purchases of Investments | (976K) | (1.09M) | 0 | (98.35M) | 0 |
| Sales of Investments | 334K | 514K | 0 | 100M | 3.71M |
| Other Investing Activities | 642K | (6.93M) | 490K | 195.41M | (50.04M) |
| Investing Cash Flow | (39.06M) | (56.44M) | (38.32M) | 134.07M | (78.28M) |
| Debt Repayment | 0 | 0 | 0 | (3.19M) | 1.65M |
| Common Stock Issued | 575M | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (406.15M) | (691.71M) | (102.05M) | (59.5M) | (91.01M) |
| Dividends Paid | (195.94M) | (181.88M) | (173.08M) | (179.02M) | (186.58M) |
| Other Financing Activities | 222.93M | (508.45M) | (1.3B) | (197.96M) | (191.4M) |
| Financing Cash Flow | 195.84M | (1.38B) | (1.57B) | (439.67M) | (467.34M) |
| Effect of Forex Changes | (161.67M) | (186.13M) | 30.44M | (52.85M) | 171.2M |
| Net Change in Cash | 861.19M | (790.61M) | (1.41B) | 384.39M | 162.75M |
| Free Cash Flow | 826.38M | 784.47M | 136.37M | 697.33M | 505.23M |
Lazard Ltd
NYSE:LAZ
Intrinsic Alpha fair value
Locked
Current Price
$39.39
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.